Virus News and Research

Latest Virus News and Research

Researchers find gene sequences of MLV in chronic fatigue syndrome patients' blood samples

Researchers have found murine leukemia viruses (MLV) related gene sequences in blood samples collected from patients diagnosed with chronic fatigue syndrome (CFS) and some healthy blood donors, according to a study published online today by the scientific journal Proceedings of the National Academy of Sciences (PNAS).

24 Aug 2010

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.

24 Aug 2010

Measles outbreak in northern NSW and Queensland

There is a confirmed measles outbreak just south of the Queensland border according to Queensland Health authorities. There have been seven cases of this highly infectious disease at Tweed Heads, NSW, including a person who reportedly visited a McDonald’s restaurant at Coolangatta over the weekend. Any residents who visited the fast food outlet between 8am and 1pm on Saturday are advised to check their vaccination status.

23 Aug 2010

Flu vaccine to be available at local pharmacies, doctor's offices

Flu vaccine will soon be available at local pharmacies and doctor's offices, and government officials are urging everyone over 6 months of age to receive it. This year's vaccine protects against H1N1 and two other strains of seasonal flu.

23 Aug 2010

Brain can act as a hiding place for HIV virus: Study

Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood.

23 Aug 2010

New antisense drugs may help treat accidental infections: Study

New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure-suggesting the approach holds promise for treating accidental infections in laboratory or hospital settings.

23 Aug 2010

Hepatitis E vaccine successful in clinical trial: Study

In a Clinical trial in China, a vaccine has been found to protect against Hepatitis E. Hepatitis E virus, usually spread via contaminated food and faeces usually runs its course before the patient recovers. However it can cause severe illness in elderly people and has a mortality rate of 1 to 3 percent. It can also kill 5 to 25 percent of affected pregnant women and those who survive can suffer high rates of miscarriage. Around a third of the world's population have been infected by the virus say researchers.

22 Aug 2010

HHS Secretary releases review of new federal approach to medical countermeasures

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today released an examination of the federal government's system to produce medications, vaccines, equipment and supplies needed for a health emergency, known as medical countermeasures. The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs reviews the process and makes recommendations for a better approach.

21 Aug 2010

HHS unveils $1.9B strategy to better prepare for biological threats

"Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, [U.S.] federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public-health emergencies," Tribune Company/Seattle Times reports.

21 Aug 2010

Scientists identify compound to treat Chagas' disease

A new compound may offer an effective drug candidate against the deadly tropical infection, Chagas' disease say researchers from Brazil. They report their findings in the August 2010 issue of the journal Antimicrobial Agents and Chemotherapy.

21 Aug 2010

CDC says teen vaccination rates up but should go higher

The Wall Street Journal writes about vaccination rates among teens: "The CDC says more teenagers got their recommended immunizations last year, but that there's room for improvement — for example, only 27% of teenage girls received the recommended three doses of human papilloma virus (HPV) vaccine.

21 Aug 2010

Cubist Pharmaceuticals ranked 31st on FORTUNE's 2010' 100 Fastest-Growing Companies' list

Cubist Pharmaceuticals, Inc. today announced it has been ranked 31st on FORTUNE's 2010 "100 Fastest-Growing Companies" list and the top pharmaceutical company. In the "Profit Growth" subgroup Cubist ranked 21st. The magazine will be on the newsstands on August 23 and the full list is available today online.

21 Aug 2010

Combination of 2 FDA approved drugs eliminate HIV infection

Researchers at the University of Minnesota Academic Health Center have identified two drugs that, when combined, may serve as an effective treatment for HIV.

21 Aug 2010

Chicago-based pasteurized eggs producer increases production following recall of salmonella-infected eggs

Chicago-based National Pasteurized Eggs today ramped up production of its industry-leading salmonella-free Davidson's Safest Choice Pasteurized Shell Eggs as federal health officials expanded the recall of eggs linked to salmonella enteritidis to 380 million.

20 Aug 2010

Research may puzzle out HIV transmission by sexual contact

The virus that causes AIDS may undergo changes in the genital tract that make HIV-1 in semen different than what it is in the blood, according to a study led by researchers from the University of North Carolina at Chapel Hill.

20 Aug 2010

General Physics to provide AAR/IP to gauge overall response to H1N1 outbreak

Global performance improvement solutions provider General Physics Corporation, a subsidiary of GP Strategies Corporation, has been selected by the Maryland Department of Public Health and Mental Hygiene to provide an After Action Report/Improvement Plan for the 2009 response to the H1N1 virus. GP will collect data from public health entities in order to gauge the overall response to the H1N1 outbreak and lessons learned, for DHMH to evaluate and consider for future pandemic response.

19 Aug 2010

Advaxis completes low dose group patient dosing in phase II cervical dysplasia clinical trial study

Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study.

19 Aug 2010

Innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells

Current HIV treatments do not eradicate HIV from host cells but rather inhibit virus replication and delay the onset of AIDS. However, a new research published in BioMed Central's open access journal, AIDS Research & Therapy describes an innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.

19 Aug 2010

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

19 Aug 2010

Study outlines recommendations for prevention, management of health epidemics

A new study reveals that the oil and gas industry supply chain which includes oil companies, contractors and sub-contractors does not perceive the full extent of the risks that HIV/AIDS, tuberculosis (TB) and malaria pose to its workforce, productivity and profitability. The study conducted by management consulting firm Booz & Company in partnership the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) outlines why the oil and gas industry should improve its understanding of the hazards posed by these three epidemics and makes ten recommendations for how to make health a priority.

19 Aug 2010

Virus News and Research

Latest Virus News and Research

Researchers find gene sequences of MLV in chronic fatigue syndrome patients' blood samples

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Measles outbreak in northern NSW and Queensland

Flu vaccine to be available at local pharmacies, doctor's offices

Brain can act as a hiding place for HIV virus: Study

New antisense drugs may help treat accidental infections: Study

Hepatitis E vaccine successful in clinical trial: Study

HHS Secretary releases review of new federal approach to medical countermeasures

HHS unveils $1.9B strategy to better prepare for biological threats

Scientists identify compound to treat Chagas' disease

CDC says teen vaccination rates up but should go higher

Cubist Pharmaceuticals ranked 31st on FORTUNE's 2010' 100 Fastest-Growing Companies' list

Combination of 2 FDA approved drugs eliminate HIV infection

Chicago-based pasteurized eggs producer increases production following recall of salmonella-infected eggs

Research may puzzle out HIV transmission by sexual contact

General Physics to provide AAR/IP to gauge overall response to H1N1 outbreak

Advaxis completes low dose group patient dosing in phase II cervical dysplasia clinical trial study

Innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Study outlines recommendations for prevention, management of health epidemics

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in